Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn | 14.41% |
| 3 | Zoetis | 31.48 Bn | 29.80 Bn | 1.05 Bn | 216.31% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 4.08% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 49.44% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -10.40% |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn | -9.38% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 134.18% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 945.77 Mn | 655.64 Mn | 93.47 Mn | -2.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.33% |
| Mar 31, 2026 | 12.21% |
| Dec 31, 2025 | 22.43% |
| Sep 30, 2025 | 3.31% |
| Jun 30, 2025 | 153.36% |
| Mar 31, 2025 | -14.17% |
| Dec 31, 2024 | -30.17% |
| Sep 30, 2024 | 96.70% |
| Jun 30, 2024 | 31.41% |
| Mar 31, 2024 | 41.00% |
| Dec 31, 2023 | 16.70% |
| Sep 30, 2023 | 157.36% |
| Jun 30, 2023 | 33.68% |
| Mar 31, 2023 | 88.83% |
| Dec 31, 2022 | 34.58% |
| Sep 30, 2022 | 67.83% |
| Jun 30, 2022 | -26.89% |
| Mar 31, 2022 | 63.87% |
| Dec 31, 2021 | 75.76% |
| Sep 30, 2021 | -32.21% |